Detalles de la búsqueda
1.
CD20 and CD37 antibodies synergize to activate complement by Fc-mediated clustering.
Haematologica
; 104(9): 1841-1852, 2019 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-30792198
2.
Type I CD20 Antibodies Recruit the B Cell Receptor for Complement-Dependent Lysis of Malignant B Cells.
J Immunol
; 197(12): 4829-4837, 2016 12 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-27807190
3.
Ibrutinib interferes with the cell-mediated anti-tumor activities of therapeutic CD20 antibodies: implications for combination therapy.
Haematologica
; 100(1): 77-86, 2015 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-25344523
4.
Response to Comment on "Type I CD20 Antibodies Recruit the B Cell Receptor for Complement-Dependent Lysis of Malignant B Cells".
J Immunol
; 200(8): 2517, 2018 04 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-29632251
5.
An Antibody-Drug Conjugate Directed to Tissue Factor Shows Preclinical Antitumor Activity in Head and Neck Cancer as a Single Agent and in Combination with Chemoradiotherapy.
Mol Cancer Ther
; 23(2): 187-198, 2024 Feb 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37828725
6.
Systematic study of tissue factor expression in solid tumors.
Cancer Rep (Hoboken)
; 6(2): e1699, 2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36806722
7.
Cytotoxicity of the CD3×CD20 bispecific antibody epcoritamab in CLL is increased by concurrent BTK or BCL-2 targeting.
Blood Adv
; 7(15): 4089-4101, 2023 08 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37219524
8.
Preclinical anti-tumour activity of HexaBody-CD38, a next-generation CD38 antibody with superior complement-dependent cytotoxic activity.
EBioMedicine
; 93: 104663, 2023 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-37379657
9.
Antibodies as drugs-a Keystone Symposia report.
Ann N Y Acad Sci
; 1519(1): 153-166, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36382536
10.
An Fc-inert PD-L1×4-1BB bispecific antibody mediates potent anti-tumor immunity in mice by combining checkpoint inhibition and conditional 4-1BB co-stimulation.
Oncoimmunology
; 11(1): 2030135, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35186440
11.
DuoBody-CD40x4-1BB induces dendritic-cell maturation and enhances T-cell activation through conditional CD40 and 4-1BB agonist activity.
J Immunother Cancer
; 10(6)2022 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35688554
12.
Preclinical Characterization and Phase I Trial Results of a Bispecific Antibody Targeting PD-L1 and 4-1BB (GEN1046) in Patients with Advanced Refractory Solid Tumors.
Cancer Discov
; 12(5): 1248-1265, 2022 05 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-35176764
13.
Potent preclinical activity of HexaBody-DR5/DR5 in relapsed and/or refractory multiple myeloma.
Blood Adv
; 5(8): 2165-2172, 2021 04 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-33885752
14.
Epcoritamab induces potent anti-tumor activity against malignant B-cells from patients with DLBCL, FL and MCL, irrespective of prior CD20 monoclonal antibody treatment.
Blood Cancer J
; 11(2): 38, 2021 02 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-33602901
15.
Dual Epitope Targeting and Enhanced Hexamerization by DR5 Antibodies as a Novel Approach to Induce Potent Antitumor Activity Through DR5 Agonism.
Mol Cancer Ther
; 19(10): 2126-2138, 2020 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-32847982
16.
DuoBody-CD3xCD20 induces potent T-cell-mediated killing of malignant B cells in preclinical models and provides opportunities for subcutaneous dosing.
EBioMedicine
; 52: 102625, 2020 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-31981978
17.
DuoHexaBody-CD37®, a novel biparatopic CD37 antibody with enhanced Fc-mediated hexamerization as a potential therapy for B-cell malignancies.
Blood Cancer J
; 10(3): 30, 2020 04 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-32341336
18.
Homogeneity of active demyelinating lesions in established multiple sclerosis.
Ann Neurol
; 63(1): 16-25, 2008 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-18232012
19.
Cooperative targeting of melanoma heterogeneity with an AXL antibody-drug conjugate and BRAF/MEK inhibitors.
Nat Med
; 24(2): 203-212, 2018 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-29334371
20.
Myelin flow cytometry assay detects enhanced levels of antibodies to human whole myelin in a subpopulation of multiple sclerosis patients.
J Neuroimmunol
; 176(1-2): 106-14, 2006 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-16712958